CytomX Therapeutics to Present at Cowen and Company 40th Annual Health Care Conference

On February 25, 2020 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody therapeutic technology platform, reported that Sean McCarthy, D.Phil., president, chief executive officer and chairman, will participate at Cowen and Company’s 40th Annual Health Care Conference in Boston, Massachusetts (Press release, CytomX Therapeutics, FEB 25, 2020, http://ir.cytomx.com/news-releases/news-release-details/cytomx-therapeutics-present-cowen-and-company-40th-annual-health [SID1234554723]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Tuesday, March 3, 2020
Time: 10:00 a.m. E.T / 7:00 a.m. P.T.
Location: Boston, Massachusetts
A live audio of this webcast will be available through the "Investors & News" section of CytomX’s website. An archived replay will be available for 60 days following the event.

Cerus Corporation to Participate in Upcoming Investor Conferences

On February 25, 2020 Cerus Corporation (Nasdaq:CERS) reported that the Company will participate in two upcoming investor conferences (Press release, Cerus, FEB 25, 2020, View Source [SID1234554721]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

William ‘Obi’ Greenman, Cerus’ president and chief executive officer and Kevin D. Green, Cerus’ chief financial officer, are scheduled to present a corporate update at the Cowen and Company 40th Annual Healthcare Conference in Boston on Tuesday, March 3rd at 8:00 A.M. ET.
Kevin D. Green is scheduled to participate in the BTIG Medtech, Digital Health, Life Science & Diagnostic Tools Conference 2020 in Snowbird on Wednesday, March 18th.
A live webcast of the presentation from Cowen’s 40th Annual Healthcare Conference will be available on the Investor Relations page of the Cerus web site at View Source A replay will be available for approximately two weeks following the completion of the event.

Cellectis to Hold Fourth Quarter and Full Year 2019 Earnings Call on Thursday, March 5, 2020 at 7:30 AM EST

On February 25, 2020 Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), reported that it will report the fourth quarter 2019 and year-end financial results on Wednesday, March 4, 2020, after the close of the US market (Press release, Cellectis, FEB 25, 2020, View Source [SID1234554720]). The announcement will be followed by a conference call at 7:30 AM EST / 1:30 PM CET on Thursday, March 5, 2020, prior to the open of the US market.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live dial-in information for the conference call is:

US & Canada only: 877-407-3104

International: 201-493-6792

In addition, a replay of the call will be available until March 19, 2020 by calling 877-660-6853 (Toll Free US & Canada); 201-612-7415 (Toll Free International), Conference ID: 13688263

Aura Biosciences to Present at the Cowen 40th Annual Health Care Conference

On February 25, 2020 Aura Biosciences, a clinical-stage biopharmaceutical company developing a new class of tumor targeted therapies for initial application in primary tumors such as ocular and bladder cancers, reported that Elisabet de los Pinos, Ph.D., Chief Executive Officer of Aura, will present a company overview at the Cowen 40th Annual Health Care Conference on Tuesday, March 3, 2020, at 9:30 a.m. Eastern Time in Boston, MA (Press release, Aura Biosciences, FEB 25, 2020, View Source [SID1234554719]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!


Alpine Immune Sciences to Present at Two Upcoming Healthcare Investor Conferences

On February 25, 2020 Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing treatments for autoimmune/inflammatory diseases and cancer, reported the company will present at two upcoming investor healthcare conferences in March (Press release, Alpine Immune Sciences, FEB 25, 2020, View Source [SID1234554718]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 40th Annual Healthcare Conference
Tuesday, March 3, 2020 at 11:20 a.m. Eastern Time in Boston, MA

Oppenheimer & Co. 30th Annual Healthcare Conference
Tuesday, March 17, 2020, at 4:30 p.m. Eastern Time in New York, NY

A live webcast of each presentation will be available online by visiting the investor relations page of the Company’s website, at View Source An archive of each webcast will be available on the Company’s website for 30 days.